When was Concordia International founded?

Concordia International was founded in 2016.

Where is Concordia International located?

Concordia International is headquartered in Oakville, Canada. It is registered at Level-5-Tower II, Phase II, Raiaskaran Tech Park Andheri Kurla Road, Andheri (East), Mumbai City, Mumbai, Maharashtra, India, 400072.

Who is the current CEO of Concordia International?

Mark Thompson of Concordia International. They have also founded 1 company.

How many employees does Concordia International have?

As of Feb 29, 2024, Concordia International has 277 employees, reflecting a 10% year-over-year growth in headcount.

Is Concordia International a funded company?

Concordia International is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Concordia International rank among its competitors?

Concordia International ranks 6th amongst 9 active competitors, none of which are funded.

Who are the top competitors of Concordia International?

Concordia International's top competitors include Cardinal Health, CNX Therapeutics and HTC. Among them, Cardinal Health secured the most recent funding round in April, 2011.

Concordia International - 2026 Company Profile, Team, Funding & Competitors

Concordia International is a funded company based in Oakville (Canada), founded in 2016 by Mark Thompson. It operates as a Distributor of speciality pharmaceutical drugs. The company has 9 active competitors, including 3 that have exited. Its top competitors include companies like Cardinal Health, CNX Therapeutics and HTC.

Company Details

Website: concordiarxinternational.com
Social
Registered Address: Level-5-Tower II, Phase II, Raiaskaran Tech Park Andheri Kurla Road, Andheri (East), Mumbai City, Mumbai, Maharashtra, India, 400072

Key Metrics

Founded Year

2016

Location

Oakville, Canada

Stage

Funding Raised

Investors

Ranked

6^th among 9 active competitors

Employee Count

277 as on Feb 29, 2024

Investment & Acquisitions

Amdipharm Mercury

Similar Companies

Cardinal Health & 206 more

View Concordia International's full profile

Concordia International is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ADVANZ PHARMA SERVICES (INDIA) PRIVATE LIMITED CIN: U74990MH1999FTC120396 , India, Active	Jun 18, 1999	$10M - $50M (As on Mar 31, 2025)	277 (As on Feb 29, 2024)

Concordia International is a funded company. Concordia International has 1 institutional investor.

View details of Concordia International's funding rounds and investors

The founders of Concordia International is Mark Thompson. Mark Thompson is the CEO of Concordia International.

Here are the details of Concordia International's key team members:

Mark Thompson: Founder & CEO of Concordia International.

View details of Concordia International's Founder profiles and Board Members

Concordia International's employee count trend

Concordia International has 277 employees as of Feb 24. Here is Concordia International's employee count trend over the years:

Employee count trend for Concordia International

Uncover Concordia International's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Concordia International include Cardinal Health, CNX Therapeutics and HTC. Here is the list of Top 10 competitors of Concordia International, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cardinal Health 1971, Dublin (United States), Public	Provider of multiple products and services for healthcare organizations	-	Elliott Management, Bain Capital Private Equity ... & 3 others	63/100
2nd	CNX Therapeutics 2021, London (United Kingdom), Funding Raised	Distributor of specialty drugs	-	Inflexion	36/100
3rd	HTC 1978, Watford (United Kingdom), Funding Raised	Supplier of pharmaceutical products	-	-	34/100
4th	Xiel 2019, Somerset (United Kingdom), Acquired	Distributor of specialist nuclear medicine and radiotherapy solutions	-	-	25/100
5th	Galen 1968, Craigavon (United Kingdom), Unfunded	Distributor of specialty drugs	-	-	25/100
6th	Concordia International 2016, Oakville (Canada), Funding Raised	Distributor of speciality pharmaceutical drugs	-	Hg	22/100
7th	Bartec Technologies 1998, Farnborough (United Kingdom), Acquired	Mediso: Advanced medical imaging systems and radioactive sources	-	-	21/100
8th	SPL Pharma 2016, London (United Kingdom), Unfunded	Distributor of specialty pharmaceutical drugs	-	-	17/100
9th	BioLab 2020, Poole (United Kingdom), Unfunded	Distributor of specialty drugs	-	-	16/100